Skip to Content
주식/증권 ➡️ 중립

ANIP Valuation: Does 9.8x Forward P/E Offer Upside?

요약

ANI Pharmaceuticals trades at 9.83x forward earnings, far below peers and its five-year median despite rising Rare Disease sales.